197 related articles for article (PubMed ID: 36197268)
21. Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas.
Zhang C; Yao C; Li H; Wang G; He X
Int J Mol Sci; 2014 Apr; 15(4):6544-55. PubMed ID: 24747591
[TBL] [Abstract][Full Text] [Related]
22. Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks.
Yang Z; Liu T; Ren X; Yang M; Tu C; Li Z
Cell Cycle; 2022 Oct; 21(20):2121-2131. PubMed ID: 35699451
[TBL] [Abstract][Full Text] [Related]
23. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
Li Q; Song S; Ni G; Li Y; Wang X
Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
[TBL] [Abstract][Full Text] [Related]
24. Identification of Serum miR-337-3p, miR-484, miR-582, and miR-3677 as Promising Biomarkers for Osteosarcoma.
Luo H; Ye Z
Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865271
[TBL] [Abstract][Full Text] [Related]
25. MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene.
Pu Y; Zhao F; Wang H; Cai S
Sci Rep; 2017 Mar; 7():44218. PubMed ID: 28281638
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.
Xu SH; Yang YL; Han SM; Wu ZH
World J Surg Oncol; 2014 Jun; 12():195. PubMed ID: 24969351
[TBL] [Abstract][Full Text] [Related]
27. miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.
Nakatani F; Ferracin M; Manara MC; Ventura S; Del Monaco V; Ferrari S; Alberghini M; Grilli A; Knuutila S; Schaefer KL; Mattia G; Negrini M; Picci P; Serra M; Scotlandi K
J Pathol; 2012 Apr; 226(5):796-805. PubMed ID: 21960059
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
Li X; Yang H; Tian Q; Liu Y; Weng Y
Neoplasma; 2014; 61(4):453-60. PubMed ID: 24645838
[TBL] [Abstract][Full Text] [Related]
29. Low expression of miR-381 is a favorite prognosis factor and enhances the chemosensitivity of osteosarcoma.
Li Y; Zhao C; Yu Z; Chen J; She X; Li P; Liu C; Zhang Y; Feng J; Fu H; Wang B; Kuang L; Li L; Lv G; Wu M
Oncotarget; 2016 Oct; 7(42):68585-68596. PubMed ID: 27612424
[TBL] [Abstract][Full Text] [Related]
30. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
[TBL] [Abstract][Full Text] [Related]
31. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
32. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-99b predicts clinical outcome of osteosarcoma and suppresses tumor cell proliferation, migration and invasion.
Shi X; Guan X
Diagn Pathol; 2019 Oct; 14(1):117. PubMed ID: 31651329
[TBL] [Abstract][Full Text] [Related]
34. Long Noncoding MT1JP Enhanced the Inhibitory Effects of miR-646 on FGF2 in Osteosarcoma.
Yang L; Liu G; Xiao S; Wang L; Liu X; Tan Q; Li Z
Cancer Biother Radiopharm; 2020 Jun; 35(5):371-376. PubMed ID: 32196384
[No Abstract] [Full Text] [Related]
35. MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma.
Lian D; Wang ZZ; Liu NS
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1258-62. PubMed ID: 27097944
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y
J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164
[TBL] [Abstract][Full Text] [Related]
37. Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer.
Zeng Z; Chen X; Zhu D; Luo Z; Yang M
Yonsei Med J; 2017 Jul; 58(4):697-702. PubMed ID: 28540980
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-145 inhibits tumour growth and metastasis in osteosarcoma by targeting cyclin-dependent kinase, CDK6.
Li Y; Liu J; Liu ZZ; Wei WB
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5117-5125. PubMed ID: 28051259
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Significance of MiR-34a Expression in Patients with Gastric Cancer after Radical Gastrectomy.
Hui WT; Ma XB; Zan Y; Wang XJ; Dong L
Chin Med J (Engl); 2015 Oct; 128(19):2632-7. PubMed ID: 26415802
[TBL] [Abstract][Full Text] [Related]
40. MiR-429 and MiR-143-3p Function as Diagnostic and Prognostic Markers for Osteosarcoma.
Yang L; Li H; Huang A
Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]